A study carried out on a group of patients among whom approximately 40% had a deletion of the IKZF1 gene showed that its presence does not affect the prognosis of BCP-ALL when it coexists with an ERG deletion. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.